Scientific paper - Original scientific paper
Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment
Cancers, 15 (2023), 3; 634. https://doi.org/10.3390/cancers15030634


Cite this document

Vrdoljak, J., Boban, Z., Barić, D., Šegvić, D., Kumrić, M., Avirović, M. ... Božić, J. (2023). Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment. Cancers, 15. (3). doi: 10.3390/cancers15030634

Vrdoljak, Josip, et al. "Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment." Cancers, vol. 15, no. 3, 2023. https://doi.org/10.3390/cancers15030634

Vrdoljak, Josip, Zvonimir Boban, Domjan Barić, Darko Šegvić, Marko Kumrić, Manuela Avirović, Melita Perić Balja, et al. "Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment." Cancers 15, no. 3 (2023). https://doi.org/10.3390/cancers15030634

Vrdoljak, J., et al. (2023) 'Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment', Cancers, 15(3). doi: 10.3390/cancers15030634

Vrdoljak J, Boban Z, Barić D, Šegvić D, Kumrić M, Avirović M, and sur.. Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment. Cancers [Internet]. 2023 January 19 [cited 2024 October 11];15(3). doi: 10.3390/cancers15030634

J. Vrdoljak, et al., "Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment", Cancers, vol. 15, no. 3, January 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:217:451410. [Accessed: 11 October 2024]

Please login to the repository to save this object to your list.